BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21493816)

  • 21. Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated from an Andersen-Tawil syndrome patient.
    Déri S; Borbás J; Hartai T; Hategan L; Csányi B; Visnyovszki Á; Madácsy T; Maléth J; Hegedűs Z; Nagy I; Arora R; Labro AJ; Környei L; Varró A; Sepp R; Ördög B
    Cardiovasc Res; 2021 Jul; 117(8):1923-1934. PubMed ID: 32810216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andersen cardiodysrhythmic periodic paralysis with KCNJ2 mutations: a novel mutation in the pore selectivity filter residue.
    Lim BC; Kim GB; Bae EJ; Noh CI; Hwang H; Kim KJ; Hwang YS; Ko TS; Chae JH
    J Child Neurol; 2010 Apr; 25(4):490-3. PubMed ID: 20382953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.
    Marrus SB; Cuculich PS; Wang W; Nerbonne JM
    Channels (Austin); 2011; 5(6):500-9. PubMed ID: 22186697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel C-terminal KCNQ1 mutation M520R alters protein trafficking.
    Schmitt N; Calloe K; Nielsen NH; Buschmann M; Speckmann EJ; Schulze-Bahr E; Schwarz M
    Biochem Biophys Res Commun; 2007 Jun; 358(1):304-10. PubMed ID: 17482572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion.
    Lange PS; Er F; Gassanov N; Hoppe UC
    Cardiovasc Res; 2003 Aug; 59(2):321-7. PubMed ID: 12909315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome.
    Fodstad H; Swan H; Auberson M; Gautschi I; Loffing J; Schild L; Kontula K
    J Mol Cell Cardiol; 2004 Aug; 37(2):593-602. PubMed ID: 15276028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome.
    Hosaka Y; Hanawa H; Washizuka T; Chinushi M; Yamashita F; Yoshida T; Komura S; Watanabe H; Aizawa Y
    J Mol Cell Cardiol; 2003 Apr; 35(4):409-15. PubMed ID: 12689820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of a double-point mutation in the KCNJ2 gene identified in a family with Andersen-Tawil syndrome.
    Fukumura S; Yamauchi K; Kawanabe A; Yamamoto A; Nakaza M; Kubota T; Kato S; Sasaki R; Okamura Y; Takahashi MP
    J Neurol Sci; 2019 Dec; 407():116521. PubMed ID: 31669729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new type of periodic paralysis: Andersen-Tawil syndrome].
    Pouget J
    Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome.
    Ballester LY; Vanoye CG; George AL
    Channels (Austin); 2007; 1(3):209-17. PubMed ID: 18690034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of KCNJ2 gene associated with Andersen-Tawil syndrome in Korean families.
    Choi BO; Kim J; Suh BC; Yu JS; Sunwoo IN; Kim SJ; Kim GH; Chung KW
    J Hum Genet; 2007; 52(3):280-283. PubMed ID: 17211524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
    Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
    Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
    Vega AL; Tester DJ; Ackerman MJ; Makielski JC
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):540-7. PubMed ID: 19843922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden cardiac death in Andersen-Tawil syndrome.
    Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
    Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Andersen-Tawil syndrome: clinical and molecular aspects.
    Nguyen HL; Pieper GH; Wilders R
    Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization.
    Ehrlich JR; Zicha S; Coutu P; Hébert TE; Nattel S
    Cardiovasc Res; 2005 Aug; 67(3):520-8. PubMed ID: 16039273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
    Tristani-Firouzi M; Etheridge SP
    Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents.
    Park SS; Ponce-Balbuena D; Kuick R; Guerrero-Serna G; Yoon J; Mellacheruvu D; Conlon KP; Basrur V; Nesvizhskii AI; Jalife J; Rual JF
    Mol Cell Proteomics; 2020 Sep; 19(9):1436-1449. PubMed ID: 32541000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
    Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
    J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
    [No Abstract]   [Full Text] [Related]  

  • 40. Andersen's syndrome mutants produce a knockdown of inwardly rectifying K
    Simkin D; Robin G; Giuliano S; Vukolic A; Moceri P; Guy N; Wagner KD; Lacampagne A; Allard B; Bendahhou S
    Cell Tissue Res; 2018 Feb; 371(2):309-323. PubMed ID: 29018970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.